ROIV
Asset Logo

Roivant Sciences Ltd.

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 3.85%
Annual Growth

4 years average annual growth

🌏

3
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Roivant Sciences Ltd. is a biopharmaceutical company focused on improving the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes product candidates across various therapeutic areas, including immunology, oncology, hematology, and dermatology. Its pipeline includes IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; brepocitinib, a small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis and non-infectious uveitis; mosliciguat, an inhaled soluble sGC activator in development for pulmonary hypertension associated with interstitial lung disease, in addition to other clinical-stage molecules; and namilumab, is a fully human monoclonal antibody targeting granulocyte-macrophage colony stimulating factor, an inflammatory cytokine involved in inflammatory disorders such as sarcoidosis.

📈 Performance

Price History*

+15.22%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$11.49

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in ROIV

3

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

45 weeks

💵 Average investment amount

$451

Last time a customer invested in ROIV

9 days
ROIV investor breakdown
💵 Income of investors

More than 200k

33%

150k - 200k

33%

100k - 150k

50k - 100k

Less than 50k

33%
👶 Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in ROIV also invest in...

Gilead Sciences Inc.

GILD

🙌 Performance (5Yr p.a)

6.97%

📊 Share price

$88.63 USD
Find Out More

🙌 Performance (5Yr p.a)

16.04%

📊 Share price

$45.28 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-12.22%

📊 Share price

$30.68 USD

🙌 Performance (5Yr p.a)

-3.94%

📊 Share price

$0.67 USD

🙌 Performance (5Yr p.a)

8.75%

📊 Share price

$24.42 USD

📈 HIGH PRICE GROWTH

Want more shares? Try these...

🙌 Performance (5Yr p.a)

8.70%

📊 Share price

$280.08 USD

📈 HIGH PRICE GROWTH

📊 Share price

$0.01 USD
Compare
Add to watchlist